Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Journal of Drugs in Dermatology : JDD|February 21, 2018
Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With RosaceaAmy W Kuang, Janet DuBois, Mayssa Attar, et al.Journal of Drugs in Dermatology : JDD|December 21, 2020
Assessing Patients' Satisfaction With Hydrogen Peroxide Topical Solution, 40% for Treatment of Raised Seborrheic KeratosesJanet DuBois, Kimberly Grande, Thomas Rhodes, et al.Journal of Drugs in Dermatology : JDD|March 15, 2018
Phase 2 Randomized, Dose-Ranging Study of Oxymetazoline Cream for Treatment of Persistent Facial Erythema Associated With RosaceaJanet DuBois, Jeffrey S Dover, Terry M Jones, et al.Journal of Drugs in Dermatology : JDD|November 16, 2020
Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 ResultsSteven Kempers, Janet DuBois, Seth Forman, et al.Clinical, Cosmetic and Investigational Dermatology|October 27, 2021
Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a TrialJanet DuBois, Suzanne Bruce, Daniel Stewart, et al.Journal of Drugs in Dermatology : JDD|June 29, 2019
Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World StudyJanet DuBois, Gavin Chun Wei Ong, Gitanjali Petkar, et al.Clinical Pharmacology in Drug Development|October 11, 2021
Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF-200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic TrialsBen Novak, Janet DuBois, Osama Chahrour, et al.JAAD International|September 13, 2024
Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm2 of the face or scalp in patients with actinic keratosis: A phase 3 studyNeal Bhatia, Edward Lain, Abel Jarell, et al.Journal of the American Academy of Dermatology|February 19, 2020
Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trialBrandon Kirsch, Stacy Smith, Joel Cohen, et al.Journal of Drugs in Dermatology : JDD|January 11, 2018
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL TrialLeon H Kircik, Janet DuBois, Zoe Diana Draelos, et al.Pageof 3